SFA Therapeutics
- Employees
- 1–10
- Website
- sfatherapeutics.com
- Total Funding
- $8.6M
- Last Round
- $4.5M BridgeSep 2023
- Rounds
- 2
About
Regulating the immune system to block cancer & autoimmune diseases
Summary
SFA Therapeutics is a Biotech company. It has raised $8.6M in total across 2 rounds, most recently a $4.5M Bridge round in Sep 2023. Investors include North South Ventures, Acequia Capital and Boost VC.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.